HomeCompareHUMDF vs QYLD

HUMDF vs QYLD: Dividend Comparison 2026

HUMDF yields 484.14% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HUMDF wins by $47899.99M in total portfolio value
10 years
HUMDF
HUMDF
● Live price
484.14%
Share price
$0.41
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47900.01M
Annual income
$34,060,653,223.60
Full HUMDF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — HUMDF vs QYLD

📍 HUMDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHUMDFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HUMDF + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HUMDF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HUMDF
Annual income on $10K today (after 15% tax)
$41,152.26/yr
After 10yr DRIP, annual income (after tax)
$28,951,555,240.06/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, HUMDF beats the other by $28,951,550,429.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HUMDF + QYLD for your $10,000?

HUMDF: 50%QYLD: 50%
100% QYLD50/50100% HUMDF
Portfolio after 10yr
$23950.02M
Annual income
$17,030,329,441.46/yr
Blended yield
71.11%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HUMDF buys
0
QYLD buys
1
PoliticianChamberTickerTypeAmountDate
Tim Moore🏢 House$QYLD▼ Sell$15,001 - $50,0002025-05-02
Tim Moore🏢 House$QYLD▲ Buy$15,001 - $50,0002025-04-07
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002022-11-14
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002020-10-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHUMDFQYLD
Forward yield484.14%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$47900.01M$25.4K
Annual income after 10y$34,060,653,223.60$5,659.31
Total dividends collected$46687.76M$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: HUMDF vs QYLD ($10,000, DRIP)

YearHUMDF PortfolioHUMDF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$59,114$48,414.43$10,352$1,192.36+$48.8KHUMDF
2$330,728$267,475.81$10,830$1,347.57+$319.9KHUMDF
3$1,752,431$1,398,551.73$11,460$1,539.07+$1.74MHUMDF
4$8,800,812$6,925,711.29$12,275$1,777.84+$8.79MHUMDF
5$41,922,789$32,505,919.38$13,323$2,078.95+$41.91MHUMDF
6$189,569,894$144,712,509.91$14,667$2,463.34+$189.56MHUMDF
7$814,403,207$611,563,420.90$16,396$2,960.57+$814.39MHUMDF
8$3,326,842,984$2,455,431,552.18$18,631$3,612.97+$3326.82MHUMDF
9$12,933,979,587$9,374,257,594.32$21,548$4,482.15+$12933.96MHUMDF
10$47,900,011,382$34,060,653,223.60$25,398$5,659.31+$47899.99MHUMDF

HUMDF vs QYLD: Complete Analysis 2026

HUMDFStock

Hua Medicine (Shanghai) Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin that is in Phase I clinical trial for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease levodopa-induced dyskinesia. The company was incorporated in 2011 and is based in Beijing, China.

Full HUMDF Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this HUMDF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HUMDF vs SCHDHUMDF vs JEPIHUMDF vs OHUMDF vs KOHUMDF vs MAINHUMDF vs XYLDHUMDF vs JEPQHUMDF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.